Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 2, 2005 - Issue 1
Submit an article Journal homepage
111
Views
35
CrossRef citations to date
0
Altmetric
Review

Targeted polymers for gene delivery

Jeffery A Hughes University of Florida, Department of Pharmaceutics, College of Pharmacy, Gainesville, Florida, USA
&
Gururaj A Rao University of Florida, Department of Pharmaceutics, College of Pharmacy, Gainesville, Florida, USA
Pages 145-157 | Published online: 22 Apr 2005

Bibliography

  • BLAU HM, SPRINGER ML: Gene therapy — a novel form of drug delivery. N Engl. J. Med. (1995) 333(18):1204–1207.
  • ANDERSON WF: September 14, 1990: the beginning. Hum. Gene Ther. (1990) 1(4):371–372.
  • CRISTIANO RJ, XU B, NGUYEN D et al.: Viral and nonviral gene delivery vectors for cancer gene therapy. Cancer Detect. Prey. (1998) 22(5):445–454.
  • CHRIST M: Preclinical evaluation of gene transfer products: safety and immunological aspects. Toxicology (2002) 174(1):13–19.
  • NISHIKAWA M, HUANG L: Nonviralvectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. (2001) 12(8):861–870.
  • LECHARDEUR D, LUKACS GL: Intracellular barriers to non-viral gene Expert Op/n. Drug Deliv. (2005) 2(1) transfer. Curr. Gene Ther. (2002) 2(2):183–194.
  • JOLLY D: Viral vector systems for gene therapy. Cancer Gene Ther. (1994) 1(1):51–64.
  • MULLIGAN RC: The basic science of gene therapy. Science (1993) 260(5110):926–932.
  • KOOTSTRA NA, VERMA IM: Gene therapy with viral vectors. Ann. Rev. Pharmacol Toxicol (2002) 25:25.
  • ECK SL, WILSON JM: Gene-based therapy. In Goodman and Gillman 's The Pharmacological Basis of Therapeutics, 9th edition. The McGraw-Hill Companies. McGraw-Hill Companies, (1995).
  • GANSBACHER B: Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT). J. Gene Med. (2003) 5(3):261–262.
  • LEHRMAN S: Virus treatment questioned after gene therapy death. Nature (1999) 401(6753):517–518.
  • HENNER WD, KLEBER I, BENZINGER R: Transfection of Escherichia coli spheroplasts. 3. Facilitation of transfection and stabilization of spheroplasts by different basic polymers. J. ViroL (1973) 12(4):741–747.
  • DE SMEDT SC, DEMEESTER J, HENNINK WE: Cationic polymer based gene delivery systems. Pharm. Res. (2000) 17(2):113–126.
  • BOUSSIF O, LEZOUALC'H F, ZANTA MA et al.: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA (1995) 92(16):7297–7301.
  • EICHMAN JD, BIELINSKA AU, KUKOWSKA-LATALLO JF, BAKER JR JR: The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. (2000) 3(7):232–245.
  • ERBACHER P, ZOU S, BETTINGER T, STEFFAN AM, REMY JS: Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res. (1998) 15(9):1332–1339.
  • TANG MX, REDEMANN CT, SZOKA FC JR: In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug-. Chem. (1996) 7(6):703–714.
  • MIYATA K, KAKIZAWA Y, NISHIYAMA N et al.: Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J. Am. Chem. Soc. (2004) 126(8):2355–2361.
  • RUDOLPH C, SCHILLINGER U, PLANK C et al.: Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. Biochim. Biophys. Acta (2002) 1573(1):75–83.
  • PETERSEN H, MERDAN T, KUNATH K, FISCHER D, KISSEL T: Poly(ethylenimine-co-L-lactamide-co-succinamide): a biodegradable polyethylenimine derivative with an advantageous pH-dependent hydrolytic degradation for gene delivery. Bioconjug-. Chem. (2002) 13(4):812–821.
  • GODBEY WT, WU KK, MIKOS AG: Poly(ethylenimine) and its role in gene delivery. J. Control. Release (1999) 60(2-3):149–160.
  • EL-ANEED A: An overview of current delivery systems in cancer gene therapy. J. Control. Release (2004) 94(1):1–14.
  • MISLICK KA, BALDESCHWIELER JD: Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl Acad. Sci. USA (1996) 93(22):12349–12354.
  • RUPONEN M, YLA-HERTTUALA S, URTTI A: Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim. Biophys. Acta (1999) 1415(2):331–341.
  • LABAT-MOLEUR F, STEFFAN AM, BRISSON C et al.: An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther. (1996) 3(11):1010–1017.
  • KOPATZ I, REMY JS, BEHR JP: A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J. Gene Med. (2004) 6(7):769–776.
  • FORREST ML, PACK DW: On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. Mol Ther. (2002) 6(1):57–66.
  • GEBHART CL, KABANOV AV: Evaluation of polyplexes as gene transfer agents. J Control Release (2001) 73(2-3):401–416.
  • KICHLER A. LEBORGNE C, COEYTAUX E, DANOS 0: Polyethylenimine-mediated gene delivery: a mechanistic study./ Gene Med. (2001) 3(2):135–144.
  • ERBACHER P, BETTINGER T, BELGUISE-VALLADIER P et al.: Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. (1999) 1(3):210–222.
  • VERBAAN FJ, OUSSOREN C, VAN DAM IM et al.: The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int. J. Pharm. (2001) 214(1-2):99–101.
  • OH YK, KIM JP, YOON H et al.: Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes. Gene Ther. (2001) 8(20):1587–1592.
  • PLANK C, MECHTLER K, SZOKA FC JR, WAGNER E: Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. (1996) 7(12):1437–1446.
  • KIRCHEIS R, SCHULLER S, BRUNNER S et al.: Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. (1999) 1(2):111–120.
  • OGRIS M, WALKER G, BLESSING T et al.: Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J. Control. Release (2003) 91(1-2):173–181.
  • KIM EM, JEONG HJ, PARK IK et al.: Monitoring the effect of pegylation on polyethylenimine in vivo using nuclear imaging technique. Nzic/. Med. Bid. (2004) 31(6):781–784.
  • KICHLER A: Gene transfer with modified polyethylenimines. J. Gene Med. (2004) 6 Suppl. 1:S3–S10.
  • SUNG SJ, MIN SH, CHO KY et al.: Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol. Pharm. Bull. (2003) 26(4):492–500.
  • MISHRA S, WEBSTER P, DAVIS ME: Pegylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. Cell Biol. (2004) 83(3):97–111.
  • MULLEN PM, LOLLO CP, PHAN QC et al.: Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivo. Biochim. Biophys. Acta (2000) 1523(1):103–110.
  • OGRIS M, BRUNNER S, SCHULLER S, KIRCHEIS R, WAGNER E: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. (1999) 6(4):595–605.
  • OUPICKY D, OGRIS M, HOWARD KA et al.: Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther (2002) 5(4):463–472.
  • KROTZ F, SOHN HY, GLOE T, PLANK C, POHL U: Magnetofection potentiates gene delivery to cultured endothelial cells. J. Vase. Res. (2003) 40(5):425–434.
  • SCHERER F, ANTON M, SCHILLINGER U et al.: Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. (2002) 9(2):102–109.
  • LI Z, NING W, WANG J et al.: Controlled gene delivery system based on thermosensitive biodegradable hydrogel. Pharm. Res. (2003) 20(6):884–888.
  • HOGSET A, PRASMICKAITE L, TJELLE TE, BERG K: Photochemical transfection: a new technology for light-induced, site-directed gene delivery. Hum. Gene Ther. (2000) 11(6):869–880.
  • TWAITES BR, DE LAS HERAS ALARCON C, CUNLIFFE D et al.: Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro. J. Control. Release (2004) 97(3):551–566.
  • PRASMICKAITE L, HOGSET A, SELBO PK et al.: Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy. Br. J. Cancer (2002) 86(4):652–657.
  • PRASMICKAITE L, HOGSET A, OLSEN VM et al.: Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir. Cancer Gene Ther. (2004) 11(7):514–523.
  • RIHOVA B: Targeting of drugs to cell surface receptors. Crit. Rev. Biotechnol (1997) 17(2):149–169.
  • OGRIS M, WAGNER E: Tumor-targeted gene transfer with DNA polyplexes. Somat. Cell Md. Genet. (2002) 27(1-0:85–95.
  • XU B, WIEHLE S, ROTH JA, CRISTIANO RJ: The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLUDNA polyplex formation. Gene Ther. (1998) 5(9):1235–1243.
  • LANCIOTTI J, SONG A, DOUKAS J et al.: Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Mo/. Ther. (2003) 8(1):99–107.
  • O'NEILL MM, KENNEDY CA, BARTON RW, TATAKE RJ: Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine. Gene Ther. (2001) 8(5):362–368.
  • SUFI W, CHUNG JK, PARK SH, KIM SW: Anti-JL1 antibody-conjugated poly (L-lysine) for targeted gene delivery to leukemia T cells. J. Control.Release (2001) 72(1-3):171–178.
  • CHEN J, GAMOU S, TAKAYANAGI A et al.: Receptor-mediated gene delivery using the Fab fragments of anti-epidermal growth factor receptor antibodies: improved immunogene approach. Cancer Gene Ther. (1998) 5(6):357–364.
  • MARUTA F, PARKER AL, FISHER KD et al.: Identification of FGF receptor-binding peptides for cancer gene therapy. Cancer Gene Ther. (2002) 9(6):543–552.
  • MERWIN JR, NOELL GS, THOMAS WL et al.: Targeted delivery of DNA using YEE(Ga1NAcAH)3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor. Bioconjug. Chem. (1994) 5(6):612–620.
  • DHARAP SS, QIU B, WILLIAMS GC et al.: Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J.Control. Release (2003) 91(1-2):61–73.
  • SAGARA K, KIM SW: A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J. Control. Release (2002) 79(1-3):271–281.
  • WU J, NANTZ MH, ZERN MA: Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci (2002) 7:717–725.
  • MCKEE TD, DEROME ME, WU GY, FINDEIS MA: Preparation of asialoorosomucoid-polylysine conjugates. Bioconjug. Chem. (1994) 5(4):306–311.
  • BENNS JM, MAHESHWARI A, FURGESON DY, MAHATO RI, KIM SW: Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J. Drug Target (2001) 9(2):123–139.
  • DIZHE EB, AKIFIEV BN, MISSUL BV et al.: Receptor-mediated transfer of DNA-galactosylated poly-L-lysine complexes into mammalian cells in vitro and in vivo. Biochemistry (2001) 66(1):55–61.
  • HOFLAND HE, MASSON C, IGINLA S et al.: Folate-targeted gene transfer in vivo. Mol Ther. (2002) 5(6):739–744.
  • GUO W, LEE RL: Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS PharmSci. (1999) 1(4):E19.
  • WARD CM, PECHAR M, OUPICKY D, ULBRICH K, SEYMOUR LW: Modification of pLUDNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J. Gene Med. (2002) 4(5):536–547.
  • HERMANSON GT: Bioconjugate Techniques. Academic Press, San Diego, (1996):xxv, 785.
  • KIM TG, KANG SY, KANG JH et al.: Gene transfer into human hepatoma cells by receptor-associated protein/polylysine conjugates. Bioconjug. Chem. (2004) 15(2):326–332.
  • MARTINEZ-FONG D, NAVARRO-QUIROGA I: Synthesis of a non-viral vector for gene transfer via the high-affinity neurotensin receptor. Brain Res. Brain Res. Protoc. (2000) 6(1-2):13–24.
  • CHIU SJ, UENO NT, LEE RJ: Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J. Control. Release (2004) 97(2):357–369.
  • VERONESE FM: Peptide and protein PEGylation: a review of problems and solutions. Biomaterials (2001) 22(5):405–417.
  • SHI L, TANG GP, GAO SJ et al.: Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord. Gene Ther. (2003) 10(14):1179–1188.
  • FOMINAYA J, WELS W: Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J. Biol. Chem. (1996) 271 (18) :10560–10568.
  • UHEREK C, FOMINAYA J, WELS W: A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery./ Biol Chem. (1998) 273(15):8835–8841.
  • MINKO T, DHARAP SS, PAKUNLU RI, WANG Y: Molecular targeting of drug delivery systems to cancer. Curr. Drug Targets (2004) 5(4):389–406.
  • RABKIN SD, MINETA T, MIYATAKE S, YAZAKI T: Gene therapy: targeting tumor cells for destruction. Hum. Cell (1996) 9 (4): 265–276.
  • MAEDA H, SAWA T, KONNO T: Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release (2001) 74(1-3):47–61.
  • MERDAN T, CALLAHAN J, PETERSEN H et al.: Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug. Chem. (2003) 14(5):989–996.
  • DASH PR, READ ML, FISHER KD et al.: Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. j Biol. Chem. (2000) 275(6):3793–3802.
  • KIRCHEIS R, OSTERMANN E, WOLSCHEK MF et al.: Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene Ther. (2002) 9(8):673–680.
  • KIRCHEIS R, BLESSING T, BRUNNER S, WIGHTMAN L, WAGNER E: Tumor targeting with surface-shielded ligand-polycation DNA complexes. J. Control. Release (2001) 72(1-3):165–170.
  • DM FH, CHEN Y, REN CC et al: Construction of an EGF receptor-mediated histone H1(0)-based gene delivery system. J. Cancer Res. Clin. Oncol (2003) 129(8):456–462.
  • ZIADY AG, FERKOL T, GERKEN T et al.: Ligand substitution of receptor targeted DNA complexes affects gene transfer into hepatoma cells. Gene Ther. (1998) 5(12):1685–1697.
  • WU GY, WU CH: Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. (1988) 263(29):14621–14624.
  • PERALES JC, FERKOL T, BEEGEN H, RATNOFF OD, HANSON RW: Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc. Nod Acad. Sci. USA (1994) 91(9):4086–4090.
  • NISHIKAWA M, TAKEMURA S, TAKAKURA Y, HASHIDA M: Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J. Pharmacol Exp. Ther. (1998) 287(1):408–415.
  • PERALES JC, GROSSMANN GA, MOLAS M et al.: Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor. J. Biol. Chem. (1997) 272(10:7398–7407.
  • MORIMOTO K, NISHIKAWA M, KAWAKAMI S et al.: Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. Mo/. Ther. (2003) 7(2):254–261.
  • COLLARD WT, YANG Y, KWOK KY, PARK Y, RICE KG: Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates. J. Pharm. Sci. (2000) 89(4):499–512.
  • NISHIKAWA M, YAMAUCHI M, MORIMOTO K et al.: Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther. (2000) 7(7):548–555.
  • BRAGONZI A, BOLETTA A, BIFFI A et al.: Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther. (1999) 6(12):1995–2004.
  • FERRARI S, PETTENAZZO A, GARBATI N et al.: Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. Biochim. Biophys. Acta (1999) 1447(2-3):219–225.
  • GAUTAM A, DENSMORE CL, XU B, WALDREP JC: Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mo/ Ther (2000) 2(1):63–70.
  • FERKOL T, PERALES JC, ECKMAN E et al.: Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. J. Clin. Invest. (1995) 95(2):493–502.
  • LI S, TAN Y, VIROONCHATAPAN E, PITT BR, HUANG L: Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am. J. PhysioL Lung Cell Mol Physiol (2000) 278(3):L504–511.
  • BARRETT LB, BERRY M, YING WB et al.: CTb targeted non-viral cDNA delivery enhances transgene expression in neurons. J. Gene Med. (2004) 6(4):429–438.
  • BARATI S, CHEGINI F, HURTADO P, RUSH RA: Hybrid tetanus toxin C fragment-diphtheria toxin translocation domain allows specific gene transfer into PC12 cells. Exp. Neurol (2002) 177(1):75–87.
  • MARTINEZ-FONG D, NAVARRO-QUIROGA I, OCHOA I et al.: Neurotensin-SPDP-poly-L-lysine conjugate: a nonviral vector for targeted gene delivery to neural cells. Brain Res. MoL Brain Res. (1999) 69(2):249–262.
  • SMREKAR B, WIGHTMAN L, WOLSCHEK MF et al.: Tissue-dependent factors affect gene delivery to tumors in vivo. Gene Ther. (2003) 10(13):1079–1088.
  • LAI WH, CAMERON PH, WADA I et al.: Ligand-mediated internalization, recycling, and downregulation of the epidermal growth factor receptor in vivo. J. Cell Biol. (1989) 109(6 Pt 0:2741–2749.
  • SCHAFFER DV, LAUFFENBURGER DA: Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery. J. Biol. Chem. (1998) 273(43):28004–28009.
  • JOST PJ, HARBOTTLE RP, KNIGHT A et al.: A novel peptide, THALWHT, for the targeting of human airway epithelia. FEBS Lett. (2001) 489(2-3):263–269.
  • FLOREA BI, MOLENAAR TJ, BOT I et al.: Identification of an internalising peptide in differentiated Calu-3 cells by phage display technology; application to gene delivery to the airways. J. Drug Target (2003) 11(7):383–390.
  • WAGNER E: Strategies to improve DNA polyplexes for in vivo gene transfer: will 'artificial viruses' be the answer? Pharm. Res. (2004) 21(1):8–14.
  • ZUBER G, DAUTY E, NOTHISEN M, BELGUISE P, BEHR JP: Towards synthetic viruses. Adv. Drug Deliv. Rev. (2001) 52(3):245–253.
  • NORI A, JENSEN KD, TIJERINA M, KOPECKOVA P, KOPECEK J: Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. Bioconjug. Chem. (2003) 14(1):44–50.
  • LUNDBERG P, LANGEL U: A brief introduction to cell-penetrating peptides. J. MoL Recognit. (2003) 16(5):227–233.
  • CARTIER R, RESZKA R: Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther. (2002) 9(3):157–167.
  • NETTELBECK DM, JEROME V MULLER R: Gene therapy: designer promoters for tumour targeting. Trends Genet. (2000) 16(4):174–181.
  • GOSSELIN MA, GUO W, LEE RJ: Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug. Chem. (2001) 12(6):989–994.
  • FORREST ML, KOERBER JT, PACK DW: A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug. Chem. (2003) 14(5):934–940.
  • KUNATH K, VON HARPE A, FISCHER D, KISSEL T: Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency. J. Control. Release (2003) 88(1):159–172.
  • FERKOL T, PERALES JC, MULARO F, HANSON RW: Receptor-mediated gene transfer into macrophages. Proc. Natl. Acad. Sci. USA (1996) 93(1):101–105.
  • DIEBOLD SS, PLANK C, GOTTEN M, WAGNER E, ZENKE M: Mannose receptor-mediated gene delivery into antigen presenting dendritic cells. Somat. Cell Md. Genet. (2002) 27(1-0:65–74.
  • BENNS JM, MAHATO RI, KIM SW: Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J. Control. Release (2002) 79(1-3):255–269.
  • CRISTIANO RJ, ROTH JA: Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther. (1996) 3(1):4–10.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.